Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 14Venous Thromboembolism 11Venous Thrombosis 4Thrombosis 3Pulmonary Embolism 3Multiple Myeloma 3Upper Extremity Deep Vein Thrombosis 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Prevention of Venous Thromboembolism 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Leukemia 1Inflammation 1Immune System Diseases 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Gastrointestinal Stromal Tumors 1

Interventions

Tranexamic Acid 12Sodium Chloride 4Misoprostol 4Saline Solution 3carbetocin 2Tourniquets 2Oxytocin 2Enoxaparin 2Endoscopic Mucosal Resection 2Dalteparin 2Vitamin B 6 1Vasopressins 1Uterine Artery Embolization 1Ultrasonography 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surveys and Questionnaires 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Lactate 1Radiotherapy 1Pancreaticoduodenectomy 1Palliative Care 1Neuromuscular Blockade 1N(4)-oleylcytosine arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemorrhage × Rivaroxaban × Clear all
NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Seoul National University Hospital

Phase 4 Completed
127 enrolled

Hemorrhage, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡